Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
Kim M Linton, Umberto Vitolo, Wojciech Jurczak, Pieternella J Lugtenburg, Emmanuel Gyan, Anna Sureda, Jacob Haaber Christensen, Brian Hess, Hervé Tilly, Raul Cordoba, David John Lewis, Craig Okada, Martin Hutchings, Michael Roost Clausen, Juan-Manuel Sancho, Tara Cochrane, Sirpa Leppä, Martine E D Chamuleau, Diana Gernhardt, Işıl Altıntaş, Yan Liu, Tahamtan Ahmadi, Minh H Dinh, Daniela Hoehn, Elena Favaro, Brian Elliott, Catherine Thieblemont, Julie M Vose
Pharmacology, Toxicology and Pharmaceutical Science
1
3%
Biochemistry, Genetics and Molecular Biology
1
3%
Engineering
1
3%
Other
0
0%
Unknown
4
14%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 413. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 September 2024.
All research outputs
#76,376
of 26,593,860 outputs
Outputs from The Lancet Haematology
#11
of 1,359 outputs
Outputs of similar age
#1,037
of 317,690 outputs
Outputs of similar age from The Lancet Haematology
#1
of 50 outputs
Altmetric has tracked 26,593,860 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,359 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.6. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 317,690 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.
